Agilent Technologies Inc. logo

Agilent Technologies Inc. (AG8)

Market Open
5 Dec, 06:37
XSTU XSTU
127. 02
-1.48
-1.15%
38.46B Market Cap
- P/E Ratio
0.94% Div Yield
0 Volume
- Eps
128.5
Previous Close
Day Range
127.02 128
Year Range
86.96 146.7
Want to track AG8 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 81 days

Summary

AG8 trading today lower at €127.02, a decrease of 1.15% from yesterday's close, completing a monthly increase of 0.33% or €0.42. Over the past 12 months, AG8 stock lost -1.81%.
AG8 pays dividends to its shareholders, with the most recent payment made on Oct 22, 2025. The next announced payment will be in In 1 month on Jan 28, 2026 for a total of €0.255.
The last earnings report, released on Nov 24, 2025, missed the consensus estimates by -1.58%. On average, the company has fell short of earnings expectations by -0.53%, based on the last three reports. The next scheduled earnings report is due on Feb 24, 2026.
Agilent Technologies Inc. has completed 1 stock splits, with the recent split occurring on Nov 03, 2014.
The company's stock is traded on 13 different exchanges and in various currencies, with the primary listing on NYSE (USD).

AG8 Chart

Agilent Technologies, Inc. (A) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Agilent Technologies, Inc. (A) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Agilent Technologies, Inc. (A) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Seekingalpha | 20 hours ago
30% of the S&P 500 Is Mag 7 Tech Stocks, but This ETF Refuses to Own a Single One

30% of the S&P 500 Is Mag 7 Tech Stocks, but This ETF Refuses to Own a Single One

The Magnificent 7 AI tech stocks have served as the rocket fuel propelling the S&P 500 on its bull run over the past few years.

247wallst | 3 days ago
Agilent (A) International Revenue Performance Explored

Agilent (A) International Revenue Performance Explored

Examine Agilent's (A) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.

Zacks | 4 days ago

Agilent Technologies Inc. (AG8) FAQ

What is the stock price today?

The current price is €127.02.

On which exchange is it traded?

Agilent Technologies Inc. is listed on NYSE.

What is its stock symbol?

The ticker symbol is AG8.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.94%.

What is its market cap?

As of today, the market cap is 38.46B.

When is the next earnings date?

The next earnings report will release on Feb 24, 2026.

Has Agilent Technologies Inc. ever had a stock split?

Agilent Technologies Inc. had 1 splits and the recent split was on Nov 03, 2014.

Agilent Technologies Inc. Profile

- Industry
- Sector
Padraig McDonnell CEO
XSTU Exchange
US00846U1016 ISIN
US Country
17,900 Employees
6 Jan 2026 Last Dividend
3 Nov 2014 Last Split
- IPO Date

Overview

Agilent Technologies, Inc. stands as a global provider offering application-focused solutions primarily to the life sciences, diagnostics, and applied chemical sectors. The company propagates its mission across three distinct segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab, ensuring a broad spectrum of scientific research, diagnostic, and analytical needs are met worldwide. Since its establishment in 1999, Agilent has cemented its headquarters in Santa Clara, California, from where it orchestrates its global operations, offering an expansive portfolio through direct sales, distributors, resellers, and electronic commerce frameworks.

Products and Services

  • Life Sciences and Applied Markets: This segment includes a vast array of technologies such as liquid and gas chromatography systems and components, mass spectrometry systems, spectroscopy instruments, and various laboratory software solutions. It extends to capturing cell analysis with plate-based assays, flow cytometers, real-time cell analyzers, and cell imaging systems, supported by laboratory automation and robotic systems. The emphasis on quality is further underscored by their vacuum pumps and measurement technologies, ensuring precision and efficiency in research and diagnostic activities.
  • Diagnostics and Genomics: Emphasizing the critical nature of genomics and nucleic acid research, this segment covers the bases from contract manufacturing to pathology and companion diagnostics. It spans a spectrum that includes reagent partnerships and biomolecular analysis, facilitating advanced diagnostics and extensive research capabilities in the genomic space. This commitment is aimed at pushing the boundaries of molecular diagnostics, providing comprehensive solutions for research and clinical applications.
  • Agilent CrossLab: A testament to Agilent’s overarching commitment to support and service, the CrossLab segment provides an exhaustive list of laboratory instrument supplies, including GC and LC columns, sample preparation products, and custom chemistries. Beyond products, CrossLab’s service portfolio is robust, offering everything from repairs, parts, and maintenance to installations, training, and compliance support. With software as a service, asset management, and consulting services, this segment is designed to optimize laboratory operations and enhance the productivity and longevity of research investments.

Contact Information

Address: 5301 Stevens Creek Boulevard
Phone: 800 227 9770